LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines.
<h4>Background</h4>LGR5 (Leucine-rich repeat-containing G-protein coupled receptor 5) is the most established marker for intestinal stem cells. Mouse models show that LGR5+ cells are the cells of origin of intestinal cancer, and LGR5 expression is elevated in human colorectal cancers, ho...
Guardado en:
Autores principales: | Francesca Walker, Hui-Hua Zhang, Annalisa Odorizzi, Antony W Burgess |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/17c6b9b10c5045ddaa12ea2b61b46ec1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
R-Spondin potentiates Wnt/β-catenin signaling through orphan receptors LGR4 and LGR5.
por: Heinz Ruffner, et al.
Publicado: (2012) -
Neonatal Wnt-dependent Lgr5 positive stem cells are essential for uterine gland development
por: Ryo Seishima, et al.
Publicado: (2019) -
Expression of LGR5 in mammary myoepithelial cells and in triple-negative breast cancers
por: Hyun Ju Lee, et al.
Publicado: (2021) -
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells
por: Ian J. Huggins, et al.
Publicado: (2017) -
RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations
por: Marcus M. Fischer, et al.
Publicado: (2017)